Improving predictions for transcatheter treatment of tricuspid valve issues
CT Prediction for Transcatheter Tricuspid Interventions
Heart and Diabetes Center North-Rhine Westfalia · NCT06951126
This study is trying to see if using advanced scans can help doctors better predict how well catheter treatments will work for people with severe tricuspid valve problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Heart and Diabetes Center North-Rhine Westfalia (other) |
| Locations | 1 site (Bad Oeynhausen, North Rhine-Westphalia) |
| Trial ID | NCT06951126 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enhance the predictability of therapeutic success in transcatheter tricuspid valve interventions for patients suffering from severe tricuspid regurgitation. By utilizing automated analyses of pre-interventional computed tomography scans, the study seeks to identify factors that contribute to successful outcomes. Given the challenges associated with severe tricuspid regurgitation, including ineffective pharmacological therapy and high surgical mortality risks, this research focuses on catheter-based treatment strategies that have shown promise in reducing regurgitation severity. The ultimate goal is to improve patient quality of life through effective intervention.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have undergone cardiac computed tomography for valvular heart disease and are scheduled for a transcatheter tricuspid valve intervention.
Not a fit: Patients who do not require a transcatheter tricuspid valve intervention or those who are not eligible for cardiac computed tomography may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better patient outcomes and improved quality of life for those undergoing transcatheter tricuspid valve interventions.
How similar studies have performed: Other studies have shown success with similar approaches in improving outcomes for transcatheter interventions, indicating a promising avenue for further research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * the patient underwent full cycle cardiac computed tomography for analysis of valvular heart disease * a transcatheter tricuspid valve intervention is performed * the patient is 18 years or older Exclusion Criteria: * none
Where this trial is running
Bad Oeynhausen, North Rhine-Westphalia
- Herz- und Diabeteszentrum — Bad Oeynhausen, North Rhine-Westphalia, Germany (RECRUITING)
Study contacts
- Study coordinator: Johannes Kirchner, Dr. med.
- Email: jkirchner@hdz-nrw.de
- Phone: 0405731971258
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Tricuspid Regurgitation, Computed Tomography, transcatheter tricuspid valve intervention, TTVI, TR, MSCT, Tricuspid regurgitation